Related references
Note: Only part of the references are listed.Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry
Maria Lazaro Salvador et al.
INTERNAL MEDICINE JOURNAL (2021)
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Marc Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies
Raymond L. Benza et al.
CHEST (2019)
Diagnosis of pulmonary hypertension
Adaani Frost et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Chronic thromboembolic pulmonary hypertension
Nick H. Kim et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pulmonary hypertension in chronic lung disease and hypoxia
Steven D. Nathan et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Risk stratification and medical therapy of pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature
Sneha M. Sundaram et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2017)
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension
Michele D'Alto et al.
CHEST (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension
Ivan M. Robbins et al.
CIRCULATION-HEART FAILURE (2014)
Lung Transplantation and Atrial Septostomy in Pulmonary Arterial Hypertension
Stephanie G. Norfolk et al.
CLINICS IN CHEST MEDICINE (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
Raymond L. Benza et al.
CHEST (2012)
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
J. Hurdman et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Survival in pulmonary hypertension in Spain: insights from the Spanish registry
Pilar Escribano-Subias et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
G. Kovacs et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)